ITAT Remands Gufic Biosciences Tax Assessment for AY2023-24 to Assessing Officer
Gufic Biosciences Ltd 路 Others (Uncategorized) 路 05 Nov 2026, 12:07 am
ITAT Remands Gufic Biosciences Tax Assessment for AY2023-24 to Assessing Officer Gufic Biosciences received an order dated 15th Oct'26 from ITAT Mumbai regarding AY23-24 assessment. Originally, an assessment order dated 18th Mar'25 levied a tax demand of Rs. 11.89 cr, later reduced to Rs. 11.76 lakh by CIT(A). Following appeals by both the Income Tax Department and the company, ITAT set aside CIT(A)'s findings and remanded the matter back to the Assessing Officer for fresh consideration. The ruling creates no immediate financial demand or operational impact; final tax liability will depend on fresh assessment outcomes.
Original exchange filing (PDF)
More announcements from Gufic Biosciences Ltd
- Intimation of Audio Recording of Earnings Conference Call held on November 16, 2026 at 04:30 p.m. is attached herewith 路 17 Nov 2026
- Investor Presentation is attached herewith 路 15 Nov 2026
- Intimation for appointment of Additional Director (Non-Executive Independent Director) of the Company is attached herewith. 路 15 Nov 2026
- Gufic Biosciences Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. 路 15 Nov 2026
- Unaudited Financial Results (Standalone and Consolidated) for the Quarter and Half Year Ended September 30, 2026 is attached herewith 路 15 Nov 2026
- Outcome of the Board of Directors Meeting held on Saturday, November 14, 2026 is attached herewith. 路 15 Nov 2026
- Intimation of Environmental, Social and Governance (''ESG'') Rating is attached herewith 路 13 Nov 2026
- Intimation of Earnings Conference Call scheduled to be held on November 16, 2026 is attached herewith 路 16 Nov 2026
